Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? Opexa Therapeutics, Inc.
Opexa Therapeutics shares gained 23.70 percent on volume of over 5 million shares traded Tuesday to close at $2.61 a share. The company has eneterd into an option and license agreement with Merck Serono for the development of Tcelna for the treatment of multiple sclerosis.
Going forward ... (see research report)
Subscribe to News Feeds